Dacmed 200 MG Injection 1 ML

Dacmed 200 MG Injection 1 ML is used for the following:

• Treatment of metastatic malignant melanoma

• Management of Hodgkin's lymphoma

• Part of combination chemotherapy protocols

• Targeting rapidly dividing cancer cells

• Disrupting DNA synthesis in malignant cells

• Fighting cancers affecting the lymphatic system

• Managing advanced stages of specific cancers

• Controlling the spread of melanoma to other body parts

Follow these guidelines when Dacmed 200 MG Injection 1 ML is administered:

• This medicine must only be given by qualified healthcare professionals.

• It is administered through an intravenous (into a vein) route.

• The injection site should be monitored for any pain or swelling.

• Proper hydration is important during treatment.

• Report any unusual symptoms to your doctor immediately.

• Your doctor will determine the appropriate treatment schedule.

• Regular blood tests will be needed to monitor your response.

Dacmed 200 MG Injection 1 ML is administered intravenously.

Dacmed 200 MG Injection 1 ML contains dacarbazine (200 mg), which works on the body as follows:

• Alkylating agent: Dacarbazine damages the DNA of cancer cells by creating cross-links between DNA strands, which prevents these cells from properly replicating their genetic material.

• Metabolic activation: Once administered, dacarbazine undergoes conversion in your body to its active form, which then interferes with DNA synthesis in rapidly dividing cells.

• Cell death induction: The DNA damage caused by dacarbazine triggers cell death pathways, ultimately destroying malignant cells that are dividing quickly.

• Selective targeting: While this medicine primarily affects cancer cells due to their rapid division rate, it can also impact normal rapidly dividing cells in your body.

• Store Dacmed 200 MG Injection 1 ML in its original packaging between 2-8°C.

• Keep the vials away from direct sunlight and moisture.

• Protect from extreme temperature changes.

• Always store out of reach of children.

• Do not use after the expiry date printed on the packaging.

• Follow hazardous waste protocols when disposing of unused medicine.

• Maintain proper hydration by drinking plenty of water during your treatment course to support kidney function and help your body process dacarbazine (the active ingredient that fights cancer cells).

• Avoid crowds and people with infections during treatment periods as this medicine can lower your white blood cell count (cells that fight infections), making you more vulnerable to illnesses.